SAN MATEO, California, December 20 /PRNewswire/ --

- With Photo

- NetSuite CEO Zach Nelson Rings Opening Bell at New York Stock Exchange

NetSuite Inc. (NYSE: N), today announced the initial public offering of 6,200,000 shares of its common stock at a price of US$26.00 per share. Its CEO Zach Nelson rang the opening bell at the New York Stock Exchange.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071220/AQTH078) (Logo: http://www.newscom.com/cgi-bin/prnh/20021024/SFTH024LOGO)

GREENSBORO, North Carolina, December 20 /PRNewswire/ --

PARIS, December 20 /PRNewswire/ -- iDOO.com is one of the first European portals to offer OpenID, a new service allowing any web surfer to use a single Internet address. The site's web server, http://www.openidoo.com, is available in Beta version.

Among the main developments in frequent surfing habits, one of the more laborious aspects is the daily connection to Internet sites. Users are waiting for improvements: simpler, faster connection without the risk of making mistakes or forgetting multiple user names and/or passwords.

A new service that helps web surfers identify themselves on the web. The principle is simple:

SAN DIEGO, December 20 /PRNewswire/ --

- Increases First Quarter Fiscal 2008 Revenue and Earnings per Share Guidance

Qualcomm Incorporated (Nasdaq: QCOM) today updated its financial guidance for the first fiscal quarter ending December 30, 2007.

The following statements are forward looking and actual results may differ materially. Please see "Note Regarding Forward-Looking Statements" at the end of this news release for a description of certain risk factors and Qualcomm's annual and quarterly reports on file with the Securities and Exchange Commission (SEC) for a more complete description of risks that may affect the forward looking statements.

Pro Forma Defined

MONTREAL, December 20 /PRNewswire/ --

- Introduces a Simpler Process Better Aligned with Industry Practices for 2008

Sipro Lab Telecom, the administrator of the G.729 Patent Pool which represents the essential IPR and has contributed to this popular communications standard developed by the G.729 Consortium members: France Telecom, Nippon Telegraph and Telephone Corporation, Mitsubishi Electric Corporation, and Universite de Sherbrooke, announced today that the patent royalty pricing options available to end-product manufacturers will be modified as of January 1st, 2008.

LONDON and CAMBRIDGE, England, December 20 /PRNewswire/ --

- ATRIPLA is a Landmark Achievement of Two Co-operating Companies

ATRIPLA (600 mg efavirenz / 200 mg emtricitabine / 245 mg tenofovir disoproxil as fumarate), launched today in the UK, is the first and only complete HIV treatment in one pill once-daily for virologically suppressed adults, and represents a new era in HIV therapy for these patients. (1,2) In a unique collaboration, two companies - Bristol-Myers Squibb and Gilead Sciences - have come together to develop a single treatment to improve the lives of people with HIV. ATRIPLA offers virologically suppressed adults effective and discreet HIV treatment in one pill, once daily.(2-5)